Acetylcholine Release Inhibitors
"Acetylcholine Release Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that block release of the neurotransmitter ACETYLCHOLINE.
| Descriptor ID |
D065087
|
| MeSH Number(s) |
D27.505.519.562.061 D27.505.519.625.120.069 D27.505.696.577.120.069
|
| Concept/Terms |
Acetylcholine Release Inhibitors- Acetylcholine Release Inhibitors
- Inhibitors, Acetylcholine Release
- Acetylcholine Release Antagonists
- Antagonists, Acetylcholine Release
- Acetylcholine Release Blockers
- Blockers, Acetylcholine Release
- Release Blockers, Acetylcholine
|
Below are MeSH descriptors whose meaning is more general than "Acetylcholine Release Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Acetylcholine Release Inhibitors".
This graph shows the total number of publications written about "Acetylcholine Release Inhibitors" by people in this website by year, and whether "Acetylcholine Release Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 2 | 0 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 2 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Acetylcholine Release Inhibitors" by people in Profiles.
-
Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal. Expert Opin Drug Saf. 2021 Jun; 20(6):695-705.
-
Botulinum Neurotoxin Injections in Childhood Opisthotonus. Toxins (Basel). 2021 02 12; 13(2).
-
Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial. Toxins (Basel). 2021 01 21; 13(2).
-
Cost-Effectiveness of Long-Term, Targeted OnabotulinumtoxinA versus Peripheral Trigger Site Deactivation Surgery for the Treatment of Refractory Migraine Headaches. Plast Reconstr Surg. 2020 Feb; 145(2):401e-406e.
-
ASGE guideline on the management of achalasia. Gastrointest Endosc. 2020 02; 91(2):213-227.e6.
-
Influence of the neural microenvironment on prostate cancer. Prostate. 2018 Feb; 78(2):128-139.
-
CEVL interactive - It is feasible for Pediatric Urology fellows to create pediatric urological surgical plans: A case study of Botox endoscopic injection. J Pediatr Urol. 2017 10; 13(5):422-425.
-
Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedules. J Neuroimmunol. 2017 05 15; 306:31-39.
-
Botulinum Toxin for the Treatment of Tremor and Tics. Semin Neurol. 2016 Feb; 36(1):54-63.
-
Botulinum toxin A-induced paralysis of the lateral abdominal wall after damage-control laparotomy: A multi-institutional, prospective, randomized, placebo-controlled pilot study. J Trauma Acute Care Surg. 2016 Feb; 80(2):237-42.